Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with IPF

被引:0
|
作者
Karampitsakos, T. [1 ]
Dimeas, I [2 ]
Tsiri, P. [1 ]
Sotiropoulou, V [1 ]
Tomos, I [3 ]
Papanikolaou, I [4 ]
Katsaras, M. [1 ]
Kirgou, P. [2 ]
Daniil, Z. [2 ]
Gourgoulianis, K. [2 ]
Papalexatos, D. [1 ]
Sampsonas, F. [1 ]
Manali, E. [3 ]
Papiris, S. [3 ]
Bouros, D. [5 ]
Tzouvelekis, A. [1 ]
Papaioannoui, o [1 ]
机构
[1] Univ Hosp Patras, Dept Resp Med, Patras, Greece
[2] Univ Thessaly, Med Sch, Dept Resp Med, Larisa, Greece
[3] Natl & Kapodistrian Univ Athens, ATTIKON Univ Hosp, Athens Med Sch, Pulm Med Dept 2, Athens, Greece
[4] Corfu Gen Hosp, Resp Med Dept, Corfu, Greece
[5] Natl & Kapodistrian Univ Athens, Hosp Thorac Dis, Acad Dept Pneumonol 1, Med Sch,SOTIRIA, Athens, Greece
关键词
D O I
10.1183/13993003.congress-2022.972
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
972
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Humoral Response to the BNT162b2 Vaccine in Hemodialysis Patients
    Yau, Kevin
    Abe, Kento T.
    Perl, Jeffrey
    Naimark, David M.
    Chan, Christopher T.
    Oliver, Matthew J.
    Colwill, Karen
    Gingras, Anne-Claude
    Hladunewich, Michelle A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 95 - 95
  • [42] Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
    Haller, Maria C.
    Kaiser, Robert A.
    Langthaler, Simon
    Brandstetter, Clara
    Apfalter, Petra
    Kerschner, Heidrun
    Cejka, Daniel
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [43] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Dagan, Noa
    Barda, Noam
    Biron-Shental, Tal
    Makov-Assif, Maya
    Key, Calanit
    Kohane, Isaac S.
    Hernan, Miguel A.
    Lipsitch, Marc
    Hernandez-Diaz, Sonia
    Reis, Ben Y.
    Balicer, Ran D.
    NATURE MEDICINE, 2021, 27 (10) : 1693 - +
  • [44] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Noa Dagan
    Noam Barda
    Tal Biron-Shental
    Maya Makov-Assif
    Calanit Key
    Isaac S. Kohane
    Miguel A. Hernán
    Marc Lipsitch
    Sonia Hernandez-Diaz
    Ben Y. Reis
    Ran D. Balicer
    Nature Medicine, 2021, 27 : 1693 - 1695
  • [45] Differential Immunogenicity of mRNA-1273 Versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative After Two BNT162b2 Doses.
    Chang, Amy
    Chiang, Teresa P. Y.
    Alejo, Jennifer L.
    Mitchell, Jonathan
    Kim, Jake D.
    Abedon, Aura T.
    Avery, Robin K.
    Tobian, Aaron A. R.
    Massie, Allan B.
    Levan, Macey L.
    Warren, Daniel S.
    Levan, Macey L.
    Warren, Daniel S.
    Garonzik-Wang, Jacqueline M.
    Segev, Dorry L.
    Werbel, William A.
    TRANSPLANTATION, 2022, 106 (09) : S3 - S3
  • [46] Factors Associated with Reduced Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) Treated with Rituximab
    Furer, Victoria
    Eviatar, Tali
    Zisman, Devy
    Peleg, Hagit
    Paran, Daphna
    Levartovsky, David
    Kaufman, Ilana
    Zisapel, Michael
    Elalouf, Ofir
    Meidan, Roni
    Broyde, Adi
    Polachek, Ari
    Wollman, Jonathan
    Meridor, Katya
    Nochomovitz, Hila
    Silberman, Adi
    Rosenberg, Dana
    Feld, Joy
    Haddad, Amir
    Gazitt, Tal
    Elias, Muna
    Hijaze, Nizar
    Kharouf, Fadi
    Shefer, Gabi
    Sharon, Orly
    Pel, Sara
    Nevo, Sharon
    Elkayam, Ori
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 897 - 901
  • [47] Antibody response to BNT162b2 mRNA vaccine in gingival crevicular fluid
    Han, Pingping
    Moran, Corey S.
    Ramachandra, Srinivas Sulugodu
    Walsh, Laurence J.
    Ivanovski, Saso
    JOURNAL OF PERIODONTOLOGY, 2023, 94 (01) : 77 - 87
  • [48] The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
    Foehse, Konstantin
    Geckin, Buesra
    Zoodsma, Martijn
    Kilic, Gizem
    Liu, Zhaoli
    Roering, Rutger J.
    Overheul, Gijs J.
    van de Maata, Josephine
    Buluta, Ozlem
    Hoogerwerf, Jacobien J.
    ten Oever, Jaap
    Simonetti, Elles
    Schaal, Heiner
    Adams, Ortwin
    Mueller, Lisa
    Ostermann, Philipp Niklas
    van de Veerdonk, Frank L.
    Joosten, Leo A. B.
    Haagmans, Bart L.
    van Crevel, Reinout
    van Rij, Ronald P.
    Geurtsvankessel, Corine
    de Jonge, Marien I.
    Li, Yang
    Dominguez-Andres, Jorge
    Netea, Mihai G.
    CLINICAL IMMUNOLOGY, 2023, 255
  • [49] Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
    Graydon, Elizabeth K.
    Conner, Tonia L.
    Dunham, Kim
    Olsen, Cara
    Goguet, Emilie
    Coggins, Si'Ana A.
    Rekedal, Marana
    Samuels, Emily
    Jackson-Thompson, Belinda
    Moser, Matthew
    Lindrose, Alyssa
    Hollis-Perry, Monique
    Wang, Gregory
    Maiolatesi, Santina
    Alcorta, Yolanda
    Reyes, Anatalio
    Wong, Mimi
    Ramsey, Kathy
    Davies, Julian
    Parmelee, Edward
    Ortega, Orlando
    Sanchez, Mimi
    Moller, Sydney
    Inglefield, Jon
    Tribble, David
    Burgess, Timothy
    O'Connell, Robert
    Malloy, Allison M. W.
    Pollett, Simon
    Broder, Christopher C.
    Laing, Eric D.
    Anderson, Stephen K.
    Mitre, Edward
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Lamb, Yvette N.
    DRUGS, 2021, 81 (04) : 495 - 501